Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In rheumatoid arthritis and osteoarthritis, the loss of extracellular matrix macromolecules, aggrecan and collagens exceeds new production, resulting in serious joint impairment. The primary cause of this loss is due to elevated proteolytic enzyme activities. Recent studies have suggested that the enzymes called 'aggrecanases' that specifically cleaves the Glu373-Ala 274 of the aggrecan core protein play a key role in the early phase of cartilage destruction. Two aggrecanases have been purified and cloned, they are designated as ADAM-TS4 and ADAM-TS5, subfamily members of the ADAM family. Recombinant ADAM-TS4 and ADAM-TS5 effectively cleave the core protein of native aggrecan, but they have little action on other protein substrates.


Journal article


Connective Tissue

Publication Date





27 - 32